Lithium therapy received approval during the 1970s, and it has been used for its
antidepressant, antimanic, and anti-suicidal effects for acute and long-term prophylaxis and …

Background Decades of clinical research have demonstrated the efficacy of lithium in
treating acute episodes (both manic and depressive), as well as in preventing recurrences of …

Dietary intervention is considered a safe preventive strategy to slow down aging. This study
aimed to evaluate the protective effects of a commercially available supplement and six …

This study was conducted to investigate the effects of long-term low-dose lithium adjunct to
antipsychotic agent use on the cognitive performance, whole-brain gray-matter volume …

Age is the number one risk factor for developing a neurodegenerative disease (ND), such as
Alzheimer's disease (AD) or Parkinson's disease (PD). With our rapidly ageing world …

Aging-related muscle loss is a hallmark of aging and is the cause of some negative
outcomes. An optimized diet and supplements have a positive effect in slowing down the …

Alzheimer's disease (AD) is the most common neuronal disorder that leads to the
development of dementia. Until nowadays, some therapies may alleviate the symptoms, but …

Increase in the quality of life, combined with drug strategies, has been studied as
possibilities for improving memory and delaying the onset of neurodegenerative diseases. A …

Background Few studies have evaluated lithium either as monotherapy or in combination
with anti-psychotic agents to improve cognition in murine models of schizophrenia. Methods …

Background: Anti-manic effects of lithium and the nature of trace element in lithium were first
observed in 1949. In this review, we explore the potential effects of trace lithium in the …